The Work We Fund

Funded projects
1,250+
Men's Health Partners
20
Countries
20
We work closely with our global men's health partners to ensure collaboration, transparency and accountability for every project we fund. We monitor this through report cards which detail what we seek to achieve, key measures and the impact.
Prostate Cancer
"Together with the brightest minds in research, we aim to achieve significant breakthroughs in the hope of beating prostate cancer. Our disruptive funding approach identifies revolutionary ways to accelerate health outcomes by creating strong, global collaborative teams." Dr. Colleen Nelson, Global Scientific Chair.
Men's Health
"One Mo can help change the face of men’s health through the powerful conversations created globally during Movember. Men have the chance to confidently discuss men’s health with people around them, resulting in men taking action early, helping change and save lives." Paul Villanti, Executive Director, Programs
Mental health and suicide prevention
“The number of men taking their own lives around the world is one of the biggest challenges of our time. Movember is working to ensure all men and boys look after their mental health and are comfortable to seek help when they’re struggling.”
Brendan Maher, Global Director, Mental Health and Suicide Prevention.
Testicular Cancer
“Despite being the 2nd most common cancer in young men, testicular cancer is often a forgotten cancer due to early detection and treatment. Our projects look at underinvested areas such as improving access to healthcare services and treatment options for relapse” Paul Villanti, Executive Director, Programs.

Translation Acceleration Grant

Movember Funding to Date

CAD 21,735,000

What we seek to achieve

The goal of the Targeted Research Grants is to address a specific and pressing concern in prostate cancer research. Each program has focused on one field of study with the aim of validating the research and translating findings into policy or practice in the short term.

Country
Canada
Co-funded
Prostate Cancer Canada: $1,462,688 CAD Distinguished Gentleman's Ride: $204,000 CAD Ontario Institute for Cancer Research: $1,498,726 CAD
Implemented by
Prostate Cancer Canada
Project start date
April 2014
Project Status
In Progress

About the project

This grant program was open to all eligible researchers based at an academic institution. It was expected that a multidisciplinary approach would be required and each application consisted of independent investigators based in multiple institutions with a lead Principal Investigator.
Selection of award recipients was made through a rigorous peer review process consisting of international reviewers.
Grants were awarded to:
•    Validate methods that will specifically and accurately distinguish between aggressive prostate cancers that need to be treated as opposed to more indolent forms of the disease (TAG1). For this project, the end goal is the clinical validation of the approach.
•    Study novel therapeutics and treatment options for metastatic and castrate resistant prostate cancer (TAG2). Projects in TAG2 are aimed at eliminating advanced prostate cancer from affected men and have the potential to enter clinical trials within 5 years of the beginning of the funding period.
•    Take novel approaches to studies focusing on the behavioural, physical, psychosocial, social/family, mental, functional, spiritual, emotional and practical concerns of daily living (Survivorship RFA). These TAG3 TrueNTH Survivorship research programs aim to influence clinical practice and should include a clear path to practical application.
•    Develop an intervention to prevent disease progression and/or improve quality of life (TAG4). TAG4 programs aim to develop an intervention that can be studied in a patient or population study within a 5-year timeframe.
•    TAG5 was open to all areas of prostate cancer research, but encouraged applications studying the prevention of progression of prostate cancer to a more advanced disease and methods to better manage therapeutic resistance. The program aims to develop an intervention that can be advanced to a clinical or population study within 3 years.
•    For TAG6, the prostate cancer research community has been asked to work collaboratively to submit one application focusing on moving a targeted radionuclide therapy into clinical practice and with encouragement to incorporate a clinical trial into the research program.

For a list of funded researchers please click here

Prostate Cancer Research Alliance

The Program will fund research that leverages Australia's existing strengths in prostate cancer biomedical research to deliver outcomes that can be translated into clinical practice within the next 5 to 7 years.

Find out more
Australia
AUD 6,150,000
USA - Mass market, multi-platform public media documentary series & campaign

This project uses a mass market, multi dimensional campaigns to shift populations understanding, attitudes and intentions and ultimately improve health outcomes on a large scale. Focusing on Youth Mental Health we will be working in partnership with PBS to deliver a documentary series supported with educational, digital and in person elements delivered across the USA.

Find out more
United States
USD 2,400,000
Men in Mind

The vision of this project is to be the ‘go to’ training resource for clinicians across the world seeking to (a) understand the needs and preferences of men, (b) gain training to better understand and respond to men's distress, (c) increase their confidence and competence in engaging with male client's, and (d) provide a gate way to Movember’s other tools, resources to stay mentally healthy and well.

Find out more
Australia
Global Funding AUD 1,521,959
Ironman Registry

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
South Africa
Global Funding AUD 18,228,055
Ironman Registry

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
Spain
Global Funding AUD 18,228,055
Ironman Registry

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
Ireland
Global Funding AUD 18,228,055
Ironman Registry

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
Switzerland
Global Funding AUD 18,228,055
Ironman Registry

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
Sweden
Global Funding AUD 18,228,055
Ironman Registry

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
United States
Global Funding AUD 18,228,055
Ironman Registry

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
United Kingdom
Global Funding AUD 18,228,055
Ironman Registry

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
Canada
Global Funding AUD 18,228,055
Ironman Registry

IRONMAN is an international, population-based registry of 5,000 men with advanced prostate cancer across ten countries. It seeks to understand clinical outcomes associated with management of advanced prostate cancer and understand the biological and clinical diversity of the disease.

Find out more
Australia
Global Funding AUD 18,228,055
Movember – Distinguished Gentleman’s Ride Clinician Scientist Award - 2017

Clinician Scientist Awards aim to support outstanding, clinically qualified professionals who have gained a PhD in health research, to combine their clinical career with a research career and establish themselves as independent researchers in the field of prostate cancer.

Find out more
Australia
-
TrueNTH Global Registry

Operating across 13 Movember countries, the TrueNTH Global Registry is an international project that aims to significantly improve the physical and mental health of men with prostate cancer.

Find out more
Australia
Global Funding AUD 18,178,871
Canadian Men's Health & Wellbeing Innovation Challenge

To support the implementation of outside the box proof of concept ideas that disrupt long held assumptions/myths about men and their health which will encourage doing things differently and ultimately lead to improved health outcomes.

Find out more
Canada
CAD 1,923,149
Prostate Cancer Outcomes - Registry Australia and New Zealand

To establish a bi-national population based registry of men who have been diagnosed with prostate cancer in order to build evidence that supports risk adjusted feedback reports for hospitals and clinicians and helps deliver improved quality of treatment and care to patients.

Find out more
Australia
AUD 22,397,860
>
Page 1 of 29